DOXWX | LLGLX | DOXWX / LLGLX | |
Total Expense Ratio | 0.52 | 1.05 | 50% |
Annual Report Gross Expense Ratio | 0.57 | 1.29 | 44% |
Fund Existence | 3 years | 13 years | - |
Gain YTD | 17.141 | 11.787 | 145% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 10000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.1B | 259M | 4,672% |
Annual Yield % from dividends | 1.76 | 2.92 | 60% |
Returns for 1 year | 1.29 | 14.18 | 9% |
Returns for 3 years | 20.17 | 32.12 | 63% |
Returns for 5 years | N/A | 26.21 | - |
Returns for 10 years | N/A | 48.27 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FPHAX | 24.89 | 0.35 | +1.43% |
Fidelity Select Pharmaceuticals Port | |||
ETCEX | 12.80 | N/A | N/A |
Eventide Exponential Technologies C | |||
QILGX | 41.30 | N/A | N/A |
Federated Hermes MDT Large Cap Growth IS | |||
OIEIX | 25.09 | -0.07 | -0.28% |
JPMorgan Equity Income A | |||
LSRCX | 1.85 | -0.02 | -1.07% |
Lord Abbett Small Cap Value C |